Global Blood Transfusion Diagnostics Market is valued at approximately USD 4.6 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.9% over the forecast period ...
The first therapy that they were advancing was targeting the blood diseases β-thalassemia and sickle cell disease. They have now been approved under the commercial name of Casgevy and for both ...
Sir John Major has been sounding off. Again. The former Tory prime minister criticised his party’s Rwanda asylum plan as ‘un-Conservative and un-British’. In an interview with the BBC, Major said he ...